Realgar nanoparticlesversusATO arsenic compounds inducein vitroandin vivoactivityagainstmultiple myeloma-Reference-Cited by-同舟云学术

Realgar nanoparticlesversusATO arsenic compounds inducein vitroandin vivoactivityagainstmultiple myeloma

Published:2017-10-19 Issue:5 Volume:179 Page:756-771
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Cholujova Danka¹,Bujnakova Zdenka²,Dutkova Erika²,Hideshima Teru³⁴,Groen Richard W.⁵,Mitsiades Constantine S.³⁴,Richardson Paul G.³⁴^ORCID,Dorfman David M.⁴⁶,Balaz Peter²,Anderson Kenneth C.³⁴,Jakubikova Jana¹³⁴^ORCID

Affiliation:

1. Cancer Research Institute; Biomedical Research Center SAS; Bratislava Slovakia

2. Institute of Geotechnics SAS; Košice Slovakia

3. Department of Medical Oncology; Jerome Lipper Multiple Myeloma Center; Dana Farber Cancer Institute; Boston MA USA

4. Department of Medicine; Harvard Medical School; Boston MA USA

5. Department of Hematology; VU University Medical Center; Amsterdam the Netherlands

6. Department of Pathology; Brigham and Women's Hospital; Boston MA USA

Funder

National Institutes of Health

Research Executive Agency

Vedecká Grantová Agentúra MŠVVaŠ SR a SAV

Agentúra na Podporu Výskumu a Vývoja

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.14974/fullpdf

Reference67 articles.

1. Efficacy and safety results with the combination therapy of arsenic trioxide, dexamethasone, and ascorbic acid in multiple myeloma patients: a phase 2 trial;Abou-Jawde;Medical Oncology,2006

2. Progress and paradigms in multiple myeloma;Anderson;Clinical Cancer Research,2016

3. Lenalidomide, bortezomib, and dexamethasone with transplantation for myeloma;Attal;New England Journal of Medicine,2017

4. Feasibility and correlates of arsenic trioxide combined with ascorbic acid-mediated depletion of intracellular glutathione for the treatment of relapsed/refractory multiple myeloma;Bahlis;Clinical Cancer Research,2002

5. Arsenic in cancer treatment: challenges for application of realgar nanoparticles (a minireview);Balaz;Toxins (Basel),2010

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. As4S4 nanoparticles promote effective terminal erythropoiesis in bone marrow mononuclear cells from patients with myelodysplastic syndromes;Nano Today;2023-10

2. Arsenic (III) and arsenic (V) removal from acidic mine waters using an acidophilic sulfate-reducing bioreactor;Hydrometallurgy;2023-08

3. Development and application of nanomaterials, nanotechnology and nanomedicine for treating hematological malignancies;Journal of Hematology & Oncology;2023-06-23

4. Nano-bio interface between As4S4 nanoparticles and albumin influenced by wet stirred media milling;International Journal of Pharmaceutics;2023-06

5. Multifunctional Nano-Realgar Hydrogel for Enhanced Glioblastoma Synergistic Chemotherapy and Radiotherapy: A New Paradigm of an Old Drug;International Journal of Nanomedicine;2023-02